The Cigna Group
Income Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $274.90B | $247.12B | $195.27B | $180.52B | $174.07B | $160.40B | $153.57B | $48.65B |
| Cost of Revenue | $214.99B | $182.51B | $133.80B | $124.83B | $117.55B | $103.48B | $97.67B | $4.79B |
| Gross Profit | $59.91B | $64.61B | $61.46B | $55.68B | $56.52B | $56.92B | $55.90B | $43.86B |
| Gross Margin | 21.8% | 26.1% | 31.5% | 30.8% | 32.5% | 35.5% | 36.4% | 90.1% |
| Operating Expenses | ||||||||
| Research & Development | — | — | — | — | — | — | — | — |
| SG&A Expense | $14.62B | $14.84B | $14.82B | $13.17B | $13.01B | $14.07B | $14.05B | $11.93B |
| Operating Income | $9.20B | $9.42B | $8.54B | $8.45B | $7.94B | $8.15B | $8.08B | $4.16B |
| Operating Margin | 3.3% | 3.8% | 4.4% | 4.7% | 4.6% | 5.1% | 5.3% | 8.6% |
| Interest Expense | $1.40B | $1.50B | $1.40B | $1.30B | $1.30B | $1.40B | $1.60B | $507.0M |
| Pretax Income | $7.78B | $5.27B | $5.51B | $8.40B | $6.79B | $10.87B | $6.57B | $3.58B |
| Income Tax Expense | $1.49B | $1.49B | $141.0M | $1.62B | $1.37B | $2.38B | $1.45B | $935.0M |
| Net Income | $5.96B | $3.43B | $5.16B | $6.78B | $5.42B | $8.49B | $5.12B | $2.65B |
| Net Margin | 2.2% | 1.4% | 2.6% | 3.8% | 3.1% | 5.3% | 3.3% | 5.4% |
| EPS (Basic) | $22.33 | $12.25 | $17.57 | $21.66 | $15.89 | $23.17 | $13.58 | $10.69 |
| EPS (Diluted) | $22.18 | $12.12 | $17.39 | $21.41 | $15.75 | $22.96 | $13.44 | $10.54 |
| Shares Outstanding (Basic) | — | — | — | — | — | — | — | — |
| Shares Outstanding (Diluted) | 268.6M | 283.2M | 296.9M | 313.1M | 341.0M | 368.4M | 379.8M | 250.2M |
| Dividends Per Share | $6.04 | $5.60 | $4.92 | $4.48 | $4.00 | $0.04 | $0.04 | $0.04 |